Edited by Didier Verhoeven, Head of the Department of Medical Oncology, AZ Klina, Brasschaat, Belgium, Cary Kaufman, Medical Director, Bellingham Regional Breast Center, Bellingham, Associate Professor of Surgery, University of Washington, Seattle, USA, Robert Mansel, President, European Commission Initiative in Breast Cancer (ECIBC), Emeritus Professor of Surgery, Cardiff University, Cardiff, UK, and Sabine Siesling, Professor, University of Twente, Enschede, and Senior Researcher, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands
Didier Verhoeven is Head of the Department of Medical Oncology at AZ Klina, and Chair of the Breast Clinic Voorkempen, in Brasschaat, Belgium, and Guest Professor at the University of Antwerp, Antwerp, Belgium.
Cary S. Kaufman is Medical Director at Bellingham Regional Breast Center, Bellingham, and Associate Professor of Surgery at the University of Washington, Seattle, USA. Previously he was President of the National Accreditation Program for Breast Centers (NAPBC), and President of the National Consortium of Breast Centers (NCBC).
Robert Mansel is Chair of the Quality Assurance Committee of the ECIBC, and Professor Emeritus of Surgery at the University of Cardiff School of Medicine, Cardiff, UK. He was formerly President of the European Society of Breast Cancer Specialists (EUSOMA).
Sabine Siesling is Professor of Outcomes Research and Personalized Cancer Care at the University of Twente, Enschede, and Senior Researcher at the Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands. She was formerly President of the Netherlands Epidemiology Society, and General Secretary of the International Association of Cancer Registries (IACR).
Philippe Aftimos, Bordet Institute, Brussels, Belgium
Claudia Allemani, London School of Hygiene and Tropical Medicine, London, UK
Benjamin O. Anderson, University of Washington, Washington, USA
Kwanele Asante-Shongwe, University of the Witwatersrand, Johannesburg, South Africa
Deanna J. Attai, David Geffen School of Medicine, University of California, Los Angeles, USA
Ahmad Awada, Bordet Institute, Brussels, Belgium
Liz Ball, Ipswich Hospital, Ipswich, UK
Baelus Benjamin, Former Advisor Lieve Wierinck MEP, Belgium
Carol Benn, University of the Witwatersrand and Helen Joseph Hospital, Johannesburg, South Africa
Annette J. Berendsen, University Medical Center Groningen, Groningen, The Netherlands
Nirmala Bhoo-Pathy, University of Malaya, Kuala Lumpur, Malaysia
Liesbeth Boersma, Maastro Clinic, Maastricht, The Netherlands
Carole Bouleuc, Curie Institute, Hopital René Huguenin, Paris, France
Etienne Brain, Curie Institute, Hopital René Huguenin, Paris, France
Freddie Bray, IACR, Lyon, France
Sara Brucker, Department of Women's Health, Tuebingen, Germany
Wolfgang Buchberger, Tirol Kliniken, Innsbruck, Austria
Barry D. Bultz, Cumming School of Medicine, University of Calgary, Alberta, Canada
Ornella Campanella, Patient Advocate, aBRCAdabra, Italy
Fatima Cardoso, Champalimaud Clinical Centre, Lisbon, Portugal
Luigi Cataliotti, President Breast Centres Certification, Florence, Italy
Eduardo L. Cazap, Latin-American & Caribbean Society of Medical Oncology (SLACOM), Buenos Aires, Argentina
AnneMarie Ciccarella, Independent Patient Advocate, New York, USA
Federico Colo, Private Institute of Oncology Alexander Fleming, Buenos Aires, Argentina
Mauricio Magelhaes Costa, Breast Center of Americas Integrated Oncology Center, Rio de Janeiro, Brazil
Mahmoud Danaei, Mariënhospital, Aachen, Germany
Evandro de Azambuja, Bordet Institute, Brussels, Belgium
Geertruida H. de Bock, University Medical Center Groningen, Groningen, The Netherlands
Wim Demey, AZ Klina Brasschaat, Belgium
Carmen Dirksen, Maastricht University Medical Centre+, Maastricht, The Netherlands
Catherine Duggan, Fred Hutchinson Cancer Research Center, Washington, USA
Francois Duhoux, Cliniques Universitaires Saint-Luc and Université Catholique de Louvain, Brussels, Belgium
Nagi El Saghir, American University of Beirut, Beirut, Lebanon
Paul A. El-Tomb, American University of Beirut, Beirut, Lebanon
Alexandru Eniu, Cancer Institute 'Ion Chiricuta', Cluj-Napoca, Romania
Marc Espié, Hôpital Saint-Louis, Paris, France
Marion Essers, Institute Verbeeten, Tilburg, The Netherlands
Carlos Garcia-Etienne, Universita degli Studi di Pavia, Pavia, Italy
Anna Gavin, Queens University Belfast, Belfast, UK
Victoria Harmer, Imperial College Healthcare NHS Trust, London, UK
Rishi Hazarika, Global Implementation and Courses ICHOM, London, UK
Teresa Heckel, Clinical Programs Sarah Cannon, Colorado Springs, USA
Sylvia Heywang-Köbrunner, Referentzzentrum Mammographie, München, Germany
Sandra Hol, Institute Verbeeten, Tilburg, The Netherlands
Aafke Honkoop, Isala Kliniek Zwolle, Zwolle, The Netherlands
Emilie Hoogland, European Parliament, Brussels, Belgium
Cathy Hughes, Imperial College Healthcare NHS Trust, London, UK
Paul B. Jacobsen, National Cancer Institute, Bethesda, USA
Stephen Jan, The George institute for Global Health, Sydney, Australia
Manuela Joore, Maastricht University Medical Centre, Maastricht, The Netherlands
Hans Junkermann, University of Heidelberg, Heidelberg, Germany
Orit Kaidar-Person, Rambam Medical Center, Haifa, Israel
Cary D. Kaufman, University of Washington, Washington, USA
Merel Kimman, Maastricht University Medical Centre+, Maastricht, The Netherlands
Betsy Kohler, NAACCR, New Jersey, USA
Nuria Kotecki, Institut Jules Bordet, Brussels, Belgium
Inge Kriel, University of Pretoria, Johannesburg, South Africa
Christine Langenaeken, AZ Klina, Brasschaat, Belgium
Daniel Leal, Plastic Surgeon, Rio De Janeiro, Brazil
Paulo Roberto Leal, Unirio, Rio De Janeiro, Brazil
Donata Lerda, ECIBC, Ispra, Italy
Ryan M.McCabe, National Cancer Data Base, American College of Surgeons, Chicago, USA
Diane M.Radford, Cleveland Clinic Foundation, Cleveland, USA
Roma Maguire, University of Strathclyde, Glasgow, UK
Robert Mansel, European Commission Initiative in Breast Cancer (ECIBC)
Christos Markopoulos, National & Kapodistrian University of Athens, Athens, Greece
Larry Marks, University of North Carolina, Chapel Hill, USA
Lorenza Marotti, EUSOMA, Florence, Italy
Shahla Masood, University of Florida, Jacksonville, USA
Tomohiro Matsuda, National Cancer Center, Tokyo, Japan
Jumana Mensah, German Cancer Society, Berlin, Germany
Michael Michell, King's College Hospital, London, UK
Alexander Mundinger, Niels-Stensen-Kliniken, Osnabrück, Germany
Groesbeck Parham, University of North Carolina, Chapel Hill, USA, and Global Women's Health Fund, Lusaka, Zambia
Johanna Pas, Patient Advocate, Antwerp, Belgium
Rudi Pauwels, Biocartis, Mechelen, Belgium
Marie-Jeanne Vrancken Peeters, Netherlands Cancer Institute, Amsterdam, The Netherlands
Sanne Peters, University of Oxford, Oxford, UK
Raghu Ram Pillarisetti, KIMS-USHALAKSHMI Centre for Breast Diseases, Hyderabad, India
Antonio Ponti, CPO Piemonte, and EUSOMA Data Centre, Turin, Italy
Philip Poortmans, Curie Institute, Paris, France
Xavier Pouwels, Maastricht University Medical Centre+, Maastricht, The Netherlands
Bram Ramaekers, Maastricht University Medical Centre+, Maastricht, The Netherlands
Peter Regitnig, Medical University of Graz, Graz, Austria
Mark E. Robson, Memorial Sloan Kettering Cancer Center, New York, USA
Julia H. Rowland, Smith Center for Healing and the Arts, Washington, USA
Fernando Suarez Saiz, IBM, Watson Health, Toronto, Canada
Roberto Salgado, GZA Hospitals, Antwerp, Belgium
Terry Sarantou, Levine Cancer Institute & Department of Surgery, Carolinas HealthCare System, Charlotte, USA
Marjanka Schmidt, Netherlands Cancer Institute, Amsterdam, The Netherlands
Gilberto Schwartsmann, Academic Hospital, Federal University, Porto Alegre, Brazil
Gary Schwitzer, HealthNewsReview.org, Minneapolis, USA
Sabine Siesling, University of Twente, Enschede, and Netherlands Comprehenisve Cancer Organisation (IKNL) Utrecht, The Netherlands
Isabelle Soerjomataram, International Agency for Research on Cancer (IARC), Lyon, France
Luis Teixeira, Diderot University, Paris, France
Soo Hwang Teo, Cancer Research Malaysia, Kuala Lumpur, Malaysia
Francisco Terrier, Breast Clinic and Italian Hospital, La Plata, Argentina
Luzia Travado, Champalimaud Clinical and Research Centre, Champalimaud Foundation, Lisbon, Portugal
Lee Tucker, Virginia Biomedical Laboratories, Virginia, USA
Jane Turner, University of Queensland, Brisbane, Australia
Peter van Dam, Multidisciplinary Breast Unit, Antwerp University Hospital, Wilrijk, Belgium
Alexandra van den Broek, Netherlands Cancer Institute, Amsterdam, The Netherlands
Gert van den Eynden, GZA Hospitals, Antwerp, Belgium
Paul van Diest, University Medical Center Utrecht, Utrecht, The Netherlands, and John Hopkins Oncology Center, Baltimore, USA
Xander Verbeek, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands
Didier Verhoeven, AZ Klina, Brasschaat, Belgium
Adri Voogd, Maastricht University, Maastricht, The Netherlands
Anna Wagstaff, Freelance Health Journalist, Oxford, UK
Simone Wesselmann, German Cancer Society, Berlin, Germany
Lieve Wierinck, Member European Parliament (MEP), Brussels, Belgium
Mark Woodward, George Institute for Global Health, University of Oxford, UK, and University of New South Wales, Sydney, Australia
Lynda Wyld, University of Sheffield, Sheffield, UK
Cheng Har Yip, University of Malaya, Kuala Lumpur, Malaysia
Sophia Zackrisson, Lund University, Malmö, Sweden
Roberto Zanetti, Piedmont Cancer Registry, Turin, Italy
